Sheel Biotech IPO
LiveAlready have an account? Apply now
Schedule of Sheel Biotech
| Issue open date | 30 Sep 2025 |
| Issue close date | 03 Oct 2025 |
| UPI mandate deadline | 03 Oct 2025 (5 PM) |
| Allotment finalization | 06 Oct 2025 |
| Refund initiation | 07 Oct 2025 |
| Share credit | 07 Oct 2025 |
| Listing date | 08 Oct 2025 |
| Mandate end date | 18 Oct 2025 |
| Lock-in end date for anchor investors (50%) | 05 Nov 2025 |
| Lock-in end date for anchor investors (remaining) | 04 Jan 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Sheel Biotech
Sheel Biotech Limited, founded in 1991, produces and supplies plants via tissue culture and organic farming. It builds and maintains greenhouses, offers farmer training and landscaping services, and runs an R&D lab with a 10 million plant capacity.
Financials of Sheel Biotech
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹34.02 crores |
| Fresh Issue | ₹34.02 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure | 9.12 (26.81%) |
| Working Capital Requirements | 15.88 (46.88%) |
| General Corporate Purpose | 9.02 (26.51%) |
Strengths
- Diversified operations across tissue culture, organic farming, landscaping, FPO training, and greenhouses.
- ISO 9001, 14001 and 45001 certifications and a DBT-recognized lab with 10 million plant capacity.
- Established presence across multiple Indian states with government and private sector clients.
- Experienced promoters with strong domain expertise and international exposure.
- Focus on farmer empowerment, skill development, and sustainable agricultural practices.
Risks
- Significant pending litigations and land acquisition disputes may impact operations.
- Dependence on timely delivery of government projects; delays may affect future bids and revenue.
- Heavy reliance on top suppliers for raw materials, exposing it to supply chain risks.
- No long-term contracts with customers; revenues largely dependent on repeat orders.
- First-time public issue with no prior trading history; market for shares uncertain
Allotment Status for Sheel Biotech
To check your allotment status – click here.
Subscription Figures for Sheel Biotech
As per media reports (Link), the Grey Market Premium (GMP) of Sheel Biotech is reported at ₹5 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on September 30, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 10.26 | 0 | 0.00x |
| NII | 7.74 | 1.02 | 0.13x |
| Retail | 18.04 | 1.36 | 0.08x |
| Total | 36.04 | 2.38 | 0.07x |